Terumo Blood and Cell Technologies’ Post

Evidence-based physician education plays an important role in market access for any new drug—whether it's the first therapy in an indication or the fourth. https://ow.ly/QHnF50SUX83 In BioPharma Dive, Norstella's Dr. Shrinal Patel and MMIT's Carolyn Zele explain why disease state education is critical. #MarketAccess #Pharma #Physicians #PhysicianEducation

The World Health Organization announced the expansion in the prequalification scope of #invitrodiagnostics. Applications for #PQ can include in vitro diagnostic medical devices for monitoring of #bloodglucose in capillary blood and #HbA1c point-of-care assays. Manufacturers interested in prequalification should contact the PQ team at [email protected] Read more: https://lnkd.in/gJcpDFEk #Background The aim of WHO prequalification of #IVDs is to promote and facilitate access to safe, appropriate and affordable #IVDs of good quality in an equitable manner. The focus is on IVDs for priority diseases that are appropriate for use in resource-limited settings. The program runs through a comprehensive, standardised assessment that has 3 components: 👉review of a product dossier 👉laboratory evaluation of performance and operational characteristics 👉manufacturing site(s) inspection The List of WHO-prequalified #InVitroDiagnostic products includes diagnostics used to diagnose a number of conditions and diseases, and that have been assessed by WHO and found to be acceptable, in principle, for procurement by #UN agencies.  List: https://lnkd.in/gJE4wjNm

"It is unconscionable to hear that AMSA, which was founded on the value of upholding the integrity of medicine above all else, is now signing away its independence to the pharmaceutical industry," dozens of doctors wrote to the American Medical Student Association board.. #medicine #doctors #physicians #medicalschool #conflicts #conflictsofinterest #students

Being a physician is not enough.  Keep learning. Different knowledge, different skills, different ways to see the same. Lets search for the another one.  https://lnkd.in/depYKuF7 #cme #novabiomedical #medicalaffairs #medicaleducation #healthcaremanagement #bbraun  #medicalscienceliaison #saúde #dialysis #ivds #pharmacology #qualidade

10 Days Until Launch: Unlocking Superior Physician CX with Deep Conversations A key strategy for transforming physician engagement is using the 'Open Mic' technique—having deep, unfiltered conversations with physicians to uncover their real needs. My co-author, Richard Vanderveer, has pioneered this approach to qualitative research. What is an Open Mic approach? It is really what it is not. It is not an in-depth interview with a detailed discussion guide. Open Mic gives physicians freedom and space to openly discuss their pain points around the experience they are receiving from pharmaceutical companies. Our book, launching on October 8th, outlines how the Open Mic approach results in candid discussions with physicians around improving communication, engagement, and ultimately, the experience physicians have with pharma.  If you’ve been relying on surface-level insights, it’s time to dive deeper and engage with physicians in a way that builds long-term trust and loyalty. #PhysicianEngagement #PharmaCX #CustomerExperience #PharmaMarketing #OpenMicTechnique

Interesting how the predictions for 2024 are almost all pointed towards patient-centric delivery and testing innovations that will most certainly leverage laboratory diagnostics to help drive better patient outcomes. Then there's the FDA and LDT regulation.....Sorry FDA, but you've never really been good at this whole laboratory diagnostics thing. CLIA, CAP, etc have done far better at assessing LDT's through practical, consistent, and applied assessment of validation and continual quality management of their performance. https://lnkd.in/eHrXQi3x

Pharmacy Assistant program students, elevate your learning with these tips! 💊 Focus on Drug Mechanisms: Understand how drugs work at the molecular level. 💊 Study Adverse Effects: Learn common side effects of major drug classes. 💊 Utilize Clinical Scenarios: Apply your knowledge to hypothetical patient situations to better understand drug choices and effects. Dive deeper into how medications impact patient care, join ACA today: https://hubs.li/Q02rhSc80

It’s the final days before a major international medical congress. Your team is scrambling. Commercial is focused on securing booth space. Medical is preparing to present cutting-edge research. And the clock is ticking. You’ve been here before. The stress. The last-minute adjustments. The feeling that things could have gone smoother if only everyone had been on the same page from the start. But what if things were different this time? What if, instead of rushing to align at the last minute, your teams were already in sync, with a clear, unified strategy that balanced both commercial and medical objectives? To find out how to achieve this, join Jabrane Annaki (Takeda) & Pierre Metrailler (SpotMe Life Sciences) for a 30-minute quickfire interview. Register now: https://lnkd.in/eVqBjaWK 🎬 "Congress Ops & Strategy: Never Too Early To Align" 🗓️ Tues, Sep 10 ⏰ 10am (ET) | 4pm (CET) 📍 Online #Congress #LifeSciences #Pharmaceuticals #Pharma #Events #EventProfs

Kits to site. Samples to lab. The basics of what the team at CellCarta Logistics is accountable for. #clinicaltrials #samplemanagement #cellcarta

Now that the FDA's final rule on LDTs is out (though not yet officially published), what's next for labs? Once they've finished reading and digesting all 528 pages of the final rule, regulatory experts Julie Ballard and Shannon Bennett will be sharing the highlights and outlining next steps for labs in our upcoming webinar, "Key Things Labs Need to Know about the FDA’s Final LDTs Rule." This one is our first-ever joint production with our colleagues at Today's Clinical Lab! If you've got any pressing questions, be sure to submit them upon registration. Join us live on May 30, or later on demand: https://lnkd.in/gyPCJCkY #FDA #LDTs #medicallaboratory #clinicallaboratory #IVDs